ArticleAntibiotics (Basel, Switzerland)2022
Optimized Synthesis of Small and Stable Silver Nanoparticles Using Intracellular and Extracellular Components of Fungi: An Alternative for Bacterial Inhibition.
Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 57 citations in OpenAlex.
- Microbial Synthesis of Precious Metal Nanoparticles and Their Applications: A Review.Microorganisms · 2026Review
- Myco-synthesized silver nanoparticles from Aspergillus niger AH1 as multifunctional anti-Helicobacter pylori agents: Antibacterial, antibiofilm, anti-urease, and antibiotic-synergistic activities.Folia microbiologica · 2026Article
- Who Reduces Silver? A Critical Review of the Biomolecular Drivers of Fungal-Mediated Silver Nanoparticle Biosynthesis.International journal of molecular sciences · 2026Review
- Antiviral Properties of Green-Synthesized Silver and Zinc Oxide Nanoparticles Against Coronaviruses: A Review.International journal of microbiology · 2026Review
- Paradoxical Features Empower Biogenic Silver Nanoparticles.Molecules (Basel, Switzerland) · 2025Review
- A novel chitosan agarose nanocopper composite film (Cs/Agr/Cu-Cu3 Biotech · 2025Article
- Biosynthesis of trimetallic nanoparticles and their biological applications: a recent review.Archives of microbiology · 2025Review
- Proteomic analysis of Trichoderma harzianum secretome and their role in the biosynthesis of zinc/iron oxide nanoparticles.Scientific reports · 2025Article
- Fusarium oxysporum assisted green synthesis of small-sized silver nanoparticles for high antibacterial, and photocatalytic decolorization performances.BMC microbiology · 2025Article
- Therapeutic Potential of Silver Nanoparticles (AgNPs) as an Antimycobacterial Agent: A Comprehensive Review.Antibiotics (Basel, Switzerland) · 2024Review
- Review
- Direct, Broad-Spectrum Antimicrobial Activity of AgMaterials (Basel, Switzerland) · 2024Article
- Silver and Gold Compounds as Antibiotics.Antibiotics (Basel, Switzerland) · 2024Article
- Biosynthesis of gold nanoparticles by fungi and its potential in SERS.Bioprocess and biosystems engineering · 2024Article
- Antimicrobial Activity of Green Synthesized Silver and Copper Oxide Nanoparticles against the Foodborne PathogenAntibiotics (Basel, Switzerland) · 2024Article
- Review
- Bio-fabrication of silver nanoparticles using Commelina erecta, L.: a mechanistic approach on synthesis, optimization, antibacterial, and antioxidant potential.Bioprocess and biosystems engineering · 2024Article
- Exploring the Antimicrobial, Antioxidant, and Antiviral Potential of Eco-Friendly Synthesized Silver Nanoparticles Using Leaf Aqueous Extract ofPharmaceuticals (Basel, Switzerland) · 2024Article
- Optimization of the biosynthesis of silver nanoparticles using bacterial extracts and their antimicrobial potential.Biotechnology reports (Amsterdam, Netherlands) · 2023Article
- Antibacterial Activity of Biosynthesized Copper Oxide Nanoparticles (CuONPs) UsingAntibiotics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticles (AgNPs) represent an excellent option to solve microbial resistance problems to traditionally used antibiotics. In this work, we report optimized protocols for the production of AgNPs using extracts and supernatants of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.